Enochian Biosciences | Investor Presentation Deck | 28 slides

Renovaro Biosciences · 2024-01
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

28
every slide · same image gating as the playbook
01
Slide 1
transition
03
inspire_vision
04
The slide uses a structured layout to present market data for three distinct cancer segments, including CAGR and projected market values.size_opportunity
Open slide detailBeat · Problem (Identify pain)Loop · Logic Chain
05
present_solution
Open slide detailBeat · Problem (Identify pain)Loop · Logic Chain
06
show_traction
Open slide detailBeat · Solution (Provide relief)Loop · Logic Chain
07
show_traction
Open slide detailBeat · Solution (Provide relief)
08
present_solution
Open slide detailBeat · Solution (Provide relief)
09
Scientific diagram illustrating the mechanism of antigen presentation and T cell maturation.establish_context
Open slide detailBeat · Solution (Provide relief)
10
The slide uses a biological diagram to explain the 'problem' of immune evasion in cancer therapy.frame_problem
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
11
The diagram uses a funnel-like or layered process flow to map biological mechanisms to specific immune outcomes.present_solution
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
12
The slide uses a process flow diagram to illustrate the 8-step manufacturing timeline.plan_implementation
Open slide detailBeat · Solution (Provide relief)
13
The slide uses a red border to highlight the RENB-DC11 row as the superior alternative.compare_peers
Open slide detailBeat · Solution (Provide relief)
14
The diagram illustrates a complex supply chain process involving biopsy, manufacturing, and clinical administration.present_framework
Open slide detailBeat · Solution (Provide relief)
15
The slide uses a combination of a process diagram and dot plots to validate the model's performance.present_solution
Open slide detailBeat · Solution (Provide relief)
16
The slide presents two bar charts (weight and volume) and a grid of tumor photographs as visual proof of concept.show_traction
Open slide detailBeat · Solution (Provide relief)
17
Includes visual evidence of tumor size alongside quantitative bar charts with statistical significance markers.show_traction
Open slide detailBeat · Solution (Provide relief)
18
The table shows 0/3 incidence of metastasis/ascites in the RENB-DC11 group compared to high incidence in control groups.show_traction
Open slide detailBeat · Solution (Provide relief)
19
The slide presents two bar charts comparing control, tumor, tumor+mock, and tumor+TD groups under different treatment conditions (IL2 vs aCD16).analyze_data
Open slide detailBeat · Solution (Provide relief)
20
N=2-3 sample size indicated at bottom left.show_traction
Open slide detailBeat · Solution (Provide relief)
21
The slide demonstrates efficacy of RENB-DC11 in stimulating immune response (IFNg production) in a tumor model.show_traction
Open slide detailBeat · Solution (Provide relief)
22
The slide uses immunohistochemistry (brown staining) to visualize CD4+ T-cells, quantified in the bar chart.show_traction
Open slide detailBeat · Solution (Provide relief)
23
The slide uses immunohistochemistry images and a corresponding bar chart to demonstrate efficacy.show_traction
Open slide detailBeat · Solution (Provide relief)
24
This is a standard TPP (Target Product Profile) table used in biotech/pharma pitch decks.present_solution
Open slide detailBeat · Solution (Provide relief)
25
The slide outlines a clinical development plan with specific milestones for 2025 and 2026, focusing on safety and efficacy cohorts.plan_implementation
Open slide detailBeat · Solution (Provide relief)
26
The slide contrasts the traditional CRO outsourcing model with a direct management model to justify cost efficiency.present_solution
Open slide detailBeat · Solution (Provide relief)
27
Standard corporate legal disclosure slide.other
Open slide detailBeat · Solution (Provide relief)
28
summarize
Open slide detailBeat · Solution (Provide relief)